|
|
Clinical effect of treating chronic refractory cough with intradermal needle regulating liver and lung |
LIU Zhiguo1,2 LI Haixia3 WANG Lei1 BIAN Yongjun1 LI Guangxi1 LI Guoqin1 RONG Yi1 KANG Xiuhong4▲ |
1.Department of Respiratory, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
2.Training Center, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
3.Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 402760, China;
4.Department of Gastroenterology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China |
|
|
Abstract Objective To study the clinical effect of treating chronic refractory cough with intradermal needle regulating liver and lung. Methods According to Excel, a random number table was generated, and the 24 patients diagnosed as liver fire invading lung type chronic refractory cough in the outpatient clinic of Guang′anmen Hospital, China Academy of Chinese Medical Sciences from June 2015 to March 2016 were divided into treatment group and control group by random, controlled and single blind method, with 12 cases in each group. Both groups were given basic treatment, on this basis, the treatment group was given intradermal needle treatment, and the control group was given true acupoint comfort needle treatment. Treatment was performed for four weeks, and one follow-up was performed after four weeks of treatment. Cough symptom score, Leicester cough questionnaire (LCQ) and cough visual analogue scale (VAS) scores were used as the main evaluation indicators. Results During the study, three cases of abscission, two cases of loss of follow-up, one case of business trip and the remaining nine cases were in the control group. Cough symptom scores: there were statistically significant differences in the time points and the interaction of daytime cough between the two groups (all P < 0.05), but no statistically significant differences between the two groups (P > 0.05). The differences of night cough score at time points were statistically significant (all P < 0.05), while the differences between the two groups and interaction were not statistically significant (all P > 0.05). Intra-group comparison: after four weeks of treatment and four weeks after the end of the treatment course, the scores of daytime cough and night cough in the treatment group were all lower than those before treatment, and the scores of night cough in the control group were lower than those before treatment (all P < 0.05). VAS score: there were statistically significant differences in the scores of cough degree and cough frequency between groups and at time points (all P < 0.05), but no statistically significant difference in the interaction (P > 0.05). The differences of night cough score at time point were statistically significant (all P < 0.05), while the differences between the two groups and interaction were not statistically significant (all P > 0.05). Intra-group comparison: after four weeks of treatment and four weeks after the end of treatment course, cough degree, cough frequency and night cough score of the two groups were all lower than those before treatment (all P < 0.05). Comparison between groups: after four weeks of treatment and four weeks after the end of treatment course, the scores of cough degree and cough frequency in the treatment group were lower than those in the control group (all P < 0.05). LCQ scores: there were statistically significant differences in the time points of the physiological, psychological and social part scores (P < 0.05), while the differences between the two groups and interaction were not statistically significant (all P > 0.05). There were no statistically significant differences between the two groups, time points and interaction in the total score (all P > 0.05). Intra-group comparison: after four weeks of treatment and four weeks after the end of treatment course, the treatment group physical parts, psychological part, social part scores were higher than those before treatment, the differences were statistically significant (all P < 0.05), four weeks after the end of treatment course, the control group psychological part, social part scores were higher than those before treatment, the differences were statistically significant (all P < 0.05). Conclusion Intradermal needle is safe and effective in treating chronic refractory cough. The therapeutic effect is mainly reflected in reducing the severity and frequency of cough.
|
|
|
|
|
[1] 余莉,陈强,邱忠民.难治性咳嗽的诊治[J].中华结核和呼吸杂志,2016,39(5):383-386.
[2] Irwin RS,Madison JM. Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease [J]. Am J Med,2000,108(Suppl 4a):126S-130S.
[3] Chung KF,Pavord ID. Prevalence,pathogenesis,and causes of chronic cough [J]. Lancet,2008,371(9621):1364-1374.
[4] He L,Li B,Chen Y,et al. Diagnosis and treatment of chronic cough in the elderly [J]. Guide of China Medicine,2012, 10:47-49.
[5] Iyer VN,Lim KG. Chronic cough:an update [J]. Mayo Clin Proc,2013,88(10):1115-1126.
[6] Chung KF. Approach to chronic cough:the neuropathic basis for cough hypersensitivity syndrome [J]. J Thorac Dis,2014,6(Suppl 7):S699-707.
[7] Haque RA,Usmani OS,Barnes PJ. Chronic idiopathic cough: a discrete clinical entity [J]. Chest,2005,127(5): 1710-1713.
[8] Randel A. ACCP Releases Guideline for the Treatment of Unexplained Chronic Cough [J]. Am Fam Physician,2016,93(11):950.
[9] 顾永丽,温燕,孙增先,等.特异性神经调节剂用于治疗难治性慢性咳嗽的研究进展[J].中华结核和呼吸杂志,2020,43(5):460-463.
[10] Vertigan AE,Theodoros DG,Gibson PG,et al. Efficacy of speech pathology management for chronic cough:a randomised placebo controlled trial of treatment efficacy [J]. Thorax,2006,61(12):1065-1069.
[11] Chamberlain S,Garrod R,Birring SS. Cough suppression therapy: does it work? [J]. Pulm Pharmacol Ther,2013, 26(5): 524-527.
[12] Murry T,Branski RC,Yu K,et al. Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder [J]. Laryngoscope,2010,120(8):1576-1581.
[13] Jiang C,Jiang L,Qin Q. Conventional Treatments plus Acupuncture for Asthma in Adults and Adolescent:A Systematic Review and Meta-Analysis [J]. Evid Based Complement Alternat Med,2019,2019:9580670.
[14] Yu M,Gao L,Kong Y,et al. Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol [J]. Medicine (Baltimore),2019,98(37):e17112.
[15] Li W,Yin P,Lao L,et al. Effectiveness of Acupuncture Used for the Management of Postpartum Depression:A Systematic Review and Meta-Analysis [J]. Biomed Res Int,2019,2019:6597503.
[16] 陈金凤,张文竹,王靖轩,等.针刺自主神经相应区域治疗慢性咳嗽[J].长春中医药大学学报,2018,34(5):919-922.
[17] 蒙剑华,李志明,刘梅英.皮内针联合中药治疗面肌痉挛的临床疗效观察[J].当代医学,2020,26(29):5-7.
[18] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南[J].中华结核和呼吸杂志,2016,39(5):323-354.
[19] 中华中医药学会内科分会肺系病专业委员会.咳嗽中医诊疗专家共识意见(2011版)[J].中医杂志,2011,52(10):896-899.
[20] Hsu JY,Stone RA,Logan-Sinclair RB,et al. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder [J]. Eur Respir J,1994,7(7):1246-1253.
[21] Fukumitsu K,Kanemitsu Y,Asano T,et al. Tiotropium Attenuates Refractory Cough and Capsaicin Cough Reflex Sensitivity in Patients with Asthma [J]. J Allergy Clin Immunol,2018,In practice 6:1613-1620.
[22] Birring SS,Prudon B,Carr AJ,et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) [J]. Thorax,2003,58(4):339-343.
[23] Morice AH,Jakes AD,Faruqi S,et al. A worldwide survey of chronic cough:a manifestation of enhanced somatosensory response [J]. Eur Respir J,2014,44(5):1149-1155.
[24] Everett CF,Kastelik JA,Thompson RH,et al. Chronic persistent cough in the community:a questionnaire survey [J]. Cough,2007,3:5.
[25] 杨存珍,陈如冲,李斌恺,等.女性慢性咳嗽患者生活质量及尿失禁调查[J].中华哮喘杂志:电子版,2010,4(4):252-255.
[26] 宗岩.从肝论治女性更年期咳嗽变异性哮喘54例[J].江苏中医药,2014(8):42-43. |
|
|
|